{
  "id": "cerebral-cavernous-malformation",
  "title": "Cerebral cavernous malformation",
  "lang": "en",
  "source_lang": "en",
  "summary": "A cerebral cavernous malformation is a cluster of abnormal, thin-walled blood vessels in the brain that may remain asymptomatic or cause seizures, neurological deficits, or bleeding.",
  "category": "health",
  "subcategory": "diseases",
  "type": "concept",
  "aliases": [
    "Cavernous malformation",
    "Cerebral cavernoma",
    "Cavernoma",
    "Cavernous angioma",
    "Cavernous hemangioma",
    "CCM"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/cerebral-cavernous-malformation/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/cerebral-cavernous-malformation/",
      "json": "https://aiwiki.page/zh/cerebral-cavernous-malformation.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "A cerebral cavernous malformation (CCM) is a vascular malformation consisting of closely packed, abnormally dilated, thin-walled blood-filled spaces in the brain. These vessels can leak blood, producing deposits of blood-breakdown products in surrounding tissue, or cause a symptomatic hemorrhage. Many lesions are discovered incidentally and never cause recognized symptoms; others cause seizures, focal neurological deficits, or recurrent bleeding. Similar malformations can occur in the spinal cord. Despite historical names such as “cavernous angioma” and “cavernous hemangioma,” a CCM is not a cancer."
    },
    {
      "heading": "Structure and biological behavior",
      "text": "A CCM typically resembles a small mulberry: multiple vascular cavities are grouped together with little or no normal brain tissue between them. Their walls consist largely of a thin endothelial lining and lack the normal structural support found in mature blood vessels. Blood flow within the cavities is slow.\n\nRepeated microscopic leakage can leave a surrounding rim of hemosiderin, an iron-containing product of blood breakdown. Local tissue irritation, scarring, and disruption of the blood–brain barrier contribute to the lesion’s effects. In lesions near the cerebral cortex, these changes can be associated with epilepsy.\n\nCCMs differ from brain arteriovenous malformations, which contain abnormal direct connections between arteries and veins and usually have much higher blood flow. CCMs also differ from an aneurysm, a localized dilation of a blood vessel.\n\nSome CCMs occur next to a developmental venous anomaly, an arrangement of veins that drains otherwise normal brain tissue. This association is particularly common in sporadic disease and matters when interpreting imaging and planning an operation."
    },
    {
      "heading": "Sporadic and familial forms",
      "text": "CCMs occur in both sporadic and inherited forms.\n\nSporadic CCM most often involves a single lesion, although multiple lesions can occur, including clusters associated with a developmental venous anomaly. The absence of a known family history does not by itself establish that a case is sporadic.\n\nFamilial CCM is commonly associated with multiple lesions and the development of additional lesions over time. It is caused by pathogenic variants in one of three established genes:\n\n- KRIT1, also called CCM1;\n- CCM2;\n- PDCD10, also called CCM3.\n\nThese genes encode proteins involved in endothelial cell signaling and vascular integrity. Familial disease follows an autosomal dominant inheritance pattern: a person carrying a causative variant has a 50% chance of passing that variant to each child. Clinical expression is variable, so relatives carrying the same variant may have very different numbers of lesions and degrees of illness.\n\nLesion formation commonly involves additional acquired genetic changes in individual vascular cells. Consequently, inheriting a pathogenic variant does not mean that every blood vessel is abnormal. Genetic testing and genetic counseling form part of the clinical assessment of suspected familial disease.\n\nCavernous malformations can also develop after cranial radiation therapy, sometimes many years after exposure."
    },
    {
      "heading": "Clinical manifestations",
      "text": "CCMs can be found at any age. Their clinical effects depend strongly on location, bleeding history, and the surrounding neural structures.\n\nPresentations include:\n\n- Incidental discovery: imaging performed for an unrelated reason reveals a lesion without attributable symptoms.\n- Seizures: particularly with lesions in or near the cerebral cortex.\n- Focal neurological deficits: weakness, sensory changes, impaired coordination, speech disturbance, or visual symptoms.\n- Symptomatic hemorrhage: bleeding associated with new or worsening symptoms.\n- Headache: sometimes associated with a lesion, although headache is common in the general population and may be unrelated.\n\nLesions in the brainstem can affect closely packed pathways controlling movement, sensation, eye movements, and other functions. Even a relatively small hemorrhage in this location may produce substantial disability.\n\nA symptomatic CCM hemorrhage is not synonymous with any MRI evidence of old bleeding. Hemosiderin and blood products of different ages are common features of CCMs, including lesions that have never caused a recognized clinical event."
    },
    {
      "heading": "Diagnosis and imaging",
      "text": "Magnetic resonance imaging is the principal method of detecting and characterizing CCMs. A typical lesion has a mixed-signal, “popcorn” or “mulberry” appearance, reflecting blood products at different stages of breakdown, surrounded by a dark hemosiderin rim.\n\nSusceptibility-sensitive sequences, particularly susceptibility-weighted imaging and T2*-weighted gradient-echo imaging, improve detection of small lesions and help establish whether lesions are solitary or multiple. Susceptibility effects can make a lesion appear larger than its anatomical extent, a phenomenon called blooming.\n\nComputed tomography can detect an acute intracerebral hemorrhage but is less sensitive than MRI for small CCMs. Catheter angiography generally does not show a CCM because of its slow flow and lack of substantial arteriovenous shunting. This accounts for the historical description “angiographically occult vascular malformation.”\n\nThe differential diagnosis includes other vascular malformations, cerebral microbleeds, hemorrhagic tumors, and other causes of blood-product deposits. A large recent hemorrhage may obscure a lesion’s characteristic appearance, with later imaging clarifying the underlying abnormality. Tissue examination after surgical removal can establish the characteristic vascular architecture, but imaging usually provides the diagnosis without biopsy."
    },
    {
      "heading": "Natural history and prognosis",
      "text": "Many incidentally detected CCMs remain clinically silent. The risk of future symptomatic hemorrhage is not uniform. Two consistently important predictors are a previous symptomatic hemorrhage and a brainstem location.\n\nBleeding risk also changes over time. After a symptomatic hemorrhage, further events may cluster during the following years rather than occurring at a constant annual rate. Published estimates vary because studies differ in patient selection, lesion location, definitions of hemorrhage, and duration of observation.\n\nIn familial disease, the development of new lesions adds another dimension to follow-up. Lesion count alone does not determine disability: one strategically located lesion may have greater consequences than numerous small asymptomatic lesions."
    },
    {
      "heading": "Management",
      "text": "Management includes observation, treatment of symptoms, and surgical removal in selected circumstances. Decisions depend on previous hemorrhage, neurological impairment, seizure control, accessibility of the lesion, and the expected risks of intervention.\n\nObservation generally involves clinical follow-up and MRI assessment. Imaging schedules vary with clinical circumstances, and there is no single universally established interval for every asymptomatic lesion. Antiseizure medication is used for CCM-associated seizures; it treats the seizures rather than removing the vascular abnormality.\n\nNeurosurgical resection can eliminate the treated lesion as a future source of hemorrhage when removal is complete. However, surgery can itself cause neurological injury, particularly in deep or functionally critical locations. A coexisting developmental venous anomaly drains normal tissue and is generally preserved during lesion surgery.\n\nStereotactic radiosurgery has been used for selected difficult-to-access lesions, but its benefit is less certain than that of complete surgical removal, and radiation-related injury is a concern. Comparative evidence is limited by differences between patients selected for observation, surgery, and radiosurgery.\n\nRehabilitation may address impairments following hemorrhage or treatment. Research into vascular signaling and lesion biology is investigating drug-based approaches, but symptom control and individualized procedural decisions remain central to established care."
    }
  ],
  "links": [
    "brain",
    "spinal-cord",
    "blood-brain-barrier",
    "cerebral-cortex",
    "epilepsy",
    "aneurysm",
    "gene",
    "radiation-therapy",
    "brainstem",
    "magnetic-resonance-imaging",
    "x-ray-computed-tomography",
    "intracerebral-hemorrhage",
    "differential-diagnosis",
    "neurosurgery",
    "rehabilitation"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}